The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth
Yayun Liang, Cynthia Besch‐Williford, Salman M. Hyder
Topics & Concepts
Estrogen receptorViability assayAngiogenesisCancer researchBreast cancerCell growthAgonistCancer cellInternal medicineEndocrinologyCancerReceptorApoptosisChemistryBiologyMedicineBiochemistryCancer, Lipids, and MetabolismPharmacological Effects of Natural CompoundsCholesterol and Lipid Metabolism